🔗 Share this article

An underground market for unlicensed weight-loss medications is propelled by social media fitness personalities and vendors on communication apps, according to new investigations.

Experimental Treatment Gaining Popularity Via Social Media

The experimental drug, which remains in research studies, is being promoted by online personalities for its alleged weight-reducing effects. Followers are encouraged to message these accounts directly for supplier links, while also obtaining discount codes.

Active Commerce on Messaging Platforms

Additionally, a flourishing market exists on Telegram, where groups with thousands of members share “before and after” images, administration instructions and claims of next-day UK delivery. Sellers market the substance there before directing customers to WhatsApp for purchases.

Learning About Retatrutide

This medication is an investigational injection created by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.

Medical Experts Voice Concerns

However, doctors and pharmacists have warned that the distribution of what is still an unapproved drug in the UK is worrisome and could result in users injecting substances of unknown origin.

Several professionals said the popularity for retatrutide could be linked to the rising price of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Implementation

Selling retatrutide on social media or messaging apps is illegal in the UK, as it is an unlicensed drug that must not be promoted or distributed for personal consumption under the British medical regulations.

Several content creators try to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still breach medicines, marketing, and consumer regulations, potentially leading to penalties, legal action or imprisonment.

Service Reaction and Material Elimination

According to the social media company, the service has taken down problematic material and prohibited related hashtags and search suggestions. The company said it was dedicated to keeping the service safe and allocating resources in strengthening enforcement strategies.

Online Trading Activities

Investigations also found communities with up to nine thousand participants selling the experimental drug using Telegram's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” immediately brings up channels with thousands of members, filled with images of weight loss, glowing reviews and step-by-step instructions for preparing or injecting at home.

Within moments of joining one community, a vendor posted WhatsApp details, where most purchases take place. The vendor provided an instruction manual and promised delivery within 48 hours. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one inquired about weight, health issues or previous experience.

Product Details and Costs

Inside these communities, posts show black plastic packages with Royal Mail labels, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at residence with purified liquid, or ready-to-use pens typically sold at £160 for 20mg. When questioned how long a injector should last, vendors give conflicting answers ranging from a several days to “depends on your body”.

Platform Moderation and Safety Measures

A spokesperson for the messaging service stated it actively moderated dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are administering substances they cannot confirm. Even if the science behind this drug is valid, these digital products may not contain what they claim,” said Jason Murphy, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to recent price rises for approved slimming drugs such as Mounjaro. “With costs increasing, patients are turning to social media. But fake treatments are highly risky. You cannot know what’s contained or whether the conditions they were made in was sterile,” she explained.

Her staff has previously encountered individuals injured by self-injection from unconfirmed sources. “We understand the disappointment, but purchasing from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be impure or incorrectly dosed.”

Manufacturer Position

A spokesperson from the pharmaceutical company stated the substance was in third stage clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this time no one can market [it] for human use,” they said, adding that any product “falsely representing itself as a company investigational product not yet approved … may expose patients to potentially significant health risks”.